These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 37569491)
1. Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review. Loveland PM; Yu JJ; Churilov L; Yassi N; Watson R Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569491 [TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation in Lewy body dementia. Surendranathan A; Rowe JB; O'Brien JT Parkinsonism Relat Disord; 2015 Dec; 21(12):1398-406. PubMed ID: 26493111 [TBL] [Abstract][Full Text] [Related]
3. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042 [TBL] [Abstract][Full Text] [Related]
4. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156 [TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders: A Meta-analysis. Mavroudis I; Petridis F; Chatzikonstantinou S; Kazis D Alzheimer Dis Assoc Disord; 2020; 34(3):220-224. PubMed ID: 32341240 [TBL] [Abstract][Full Text] [Related]
6. Systematic review of gene expression studies in people with Lewy body dementia. Chowdhury A; Rajkumar AP Acta Neuropsychiatr; 2020 Dec; 32(6):281-292. PubMed ID: 32178745 [TBL] [Abstract][Full Text] [Related]
7. Systematic review of genetic association studies in people with Lewy body dementia. Sanghvi H; Singh R; Morrin H; Rajkumar AP Int J Geriatr Psychiatry; 2020 May; 35(5):436-448. PubMed ID: 31898332 [TBL] [Abstract][Full Text] [Related]
8. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478 [TBL] [Abstract][Full Text] [Related]
9. Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia. Maetzler W; Tian Y; Baur SM; Gauger T; Odoj B; Schmid B; Schulte C; Deuschle C; Heck S; Apel A; Melms A; Gasser T; Berg D PLoS One; 2012; 7(10):e48042. PubMed ID: 23133543 [TBL] [Abstract][Full Text] [Related]
11. Single-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort. Phongpreecha T; Mathi K; Cholerton B; Fox EJ; Sigal N; Espinosa C; Reincke M; Chung P; Hwang LJ; Gajera CR; Berson E; Perna A; Xie F; Shu CH; Hazra D; Channappa D; Dunn JE; Kipp LB; Poston KL; Montine KS; Maecker HT; Aghaeepour N; Montine TJ Mol Neurodegener; 2024 Aug; 19(1):59. PubMed ID: 39090623 [TBL] [Abstract][Full Text] [Related]
12. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients. Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836 [TBL] [Abstract][Full Text] [Related]
13. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum. Sierra M; Gelpi E; Martí MJ; Compta Y Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462 [TBL] [Abstract][Full Text] [Related]
14. Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy. Urbizu A; Beyer K Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630630 [TBL] [Abstract][Full Text] [Related]
15. Pathology-associated change in levels and localization of SIDT2 in postmortem brains of Parkinson's disease and dementia with Lewy bodies patients. Fujiwara Y; Kabuta C; Sano T; Murayama S; Saito Y; Kabuta T Neurochem Int; 2022 Jan; 152():105243. PubMed ID: 34800582 [TBL] [Abstract][Full Text] [Related]
16. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions. Walker L; Stefanis L; Attems J J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688 [TBL] [Abstract][Full Text] [Related]
17. Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation. Rajkumar AP; Bidkhori G; Shoaie S; Clarke E; Morrin H; Hye A; Williams G; Ballard C; Francis P; Aarsland D Am J Geriatr Psychiatry; 2020 Jan; 28(1):75-86. PubMed ID: 31327631 [TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Rolinski M; Fox C; Maidment I; McShane R Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206 [TBL] [Abstract][Full Text] [Related]
20. Systemic Inflammation in Lewy Body Diseases: A Systematic Review. King E; Thomas A Alzheimer Dis Assoc Disord; 2017; 31(4):346-356. PubMed ID: 29016447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]